Transforming Discovery into Opportunity

New Federal Funding Enables CDRD and CDRD Ventures Inc. to Expand Support to Canadian Entrepreneurs…

….Read more 

Find out how CDRD and CDRD Ventures can now support Canadian Health Sciences Companies…..

Read more about our Opportunities for Industry……

UBC Pharmaceutical Sciences Building, home of The Centre for Drug Research and Development and CDRD Ventures Inc.

The Plight of Ebola: Canadian Researchers Come Together to Combat the Outbreak

Click here for the full story

November 18th, 2014 — CDRD CEO Karimah Es Sabar receives Distinguished Alumni Award from her Alma Mater, the University of Salford, UK

CDRD BY THE NUMBERS:

  • Over 1,000 early-stage technologies evaluated for their commercial potential
  • Over 210 projects undertaken on 135 distinct technologies
  • 56 technologies advanced toward commercialization and/or commercialized
  • 4 Spin-Off Companies
  • 3 Out-Licenses
  • 3 Under Current Development / Management of CVI

“”My transition from a postdoctoral fellow to an associate scientist position truly exemplifies CDRD’s mandate to train and develop the next generation of highly qualified young professionals in drug development research.”
- Dr.Pauline So, Associate Scientist, Target Validation

Our latest Trainee Spotlight focuses on Dr. Céline Hodler, our current Post-Doctoral Fellow in our Pharmacology/Toxicology Division.  Click here to find out more about Céline’s achievements.

What is CDRD?

The Centre for Drug Research and Development (CDRD) is Canada’s fully-integrated national drug development and commercialization centre, providing expertise and infrastructure to enable researchers from leading health research institutions to advance promising early-stage drug candidates. Our mandate is to de-risk discoveries stemming from publicly-funded health research and transform them into viable investment opportunities for the private sector — thus successfully bridging the commercialization gap between academia and industry, and translating research discoveries into new therapies for patients. Canada’s Networks of Centres of Excellence Program has recognized CDRD as a Centre of Excellence for Commercialization and Research (CECR).

NEW: Find our how CDRD and CVI can now support Canadian health sciences companies…..

+ LEARN MORE

Latest from the Blog

The Immunotherapy Advantage….

Antipsychotics Against Schizophrenia: A Drug Pipeline That’s Running Dry?

+ VISIT THE BLOG

Latest from Twitter


+ FOLLOW US ON TWITTER



A Shared Vision










  • Industry
  • Academia
  • Government

Sign up to our newsletter

Receive CDRD’s and CVI's quarterly e-newsletter, The CDRD Pipeline and other e-communications for regular updates on all our news and activities.



© Copyright 2014 CDRD. All rights reserved.